EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026

2017-06-01
Price :
Published : Jun-2017
No. of Pages : 45
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Venous Thromboembolism: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Related Reports 6
3 Introduction 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.4 Forecast Methodology 11
3.4.1 Sources 11
3.4.2 Forecast Assumptions and Methods 13
3.5 Epidemiological Forecast for VTE (2016-2026) 24
3.5.1 Diagnosed Incident Cases of Pulmonary Embolism 24
3.5.2 Diagnosed Incident Cases of Deep Vein Thrombosis 25
3.5.3 Diagnosed Incident Cases of VTE 26
3.5.4 Age-Specific Diagnosed Incident Cases of VTE 28
3.5.5 Sex-Specific Diagnosed Incident Cases of VTE 29
3.5.6 One- and 10-Year First Time Recurrent Cases of VTE 29
3.5.7 Number of VTE Cases with Cancer as Comorbidity 30
3.5.8 Number of VTE Attacks 31
3.5.9 Number of Hospital Discharges Meeting Criteria for Medically Ill and Those at Risk for VTE 31
3.5.10 Number of Primary Total Knee Replacements and Revisions 32
3.5.11 Number of Hip Replacements 33
3.6 Discussion 34
3.6.1 Epidemiological Forecast Insight 34
3.6.2 Limitations of the Analysis 35
3.6.3 Strengths of the Analysis 35
4 Appendix 36
4.1 Bibliography 36
4.2 Physicians and Specialists Included in this Study 38
4.3 Primary Research - Key Opinion Leaders Interviewed for this Report 40
4.4 About the Authors 43
4.4.1 Epidemiologist 43
4.4.2 Reviewers 43
4.4.3 Global Director of Therapy Analysis and Epidemiology 44
4.4.4 Global Head and EVP of Healthcare Operations and Strategy 44
4.5 About GlobalData 44
4.6 Contact Us 45
4.7 Disclaimer 45

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Venous Thromboembolism 8
Table 2: 7MM, Diagnosed Incident Cases of PE, Men and Women, All Ages, N, Select Years, 2016-2026 25
Table 3: 7MM, Diagnosed Incident Cases of DVT, Men and Women, All Ages, N, Select Years, 2016-2026 26
Table 4: 7MM, Diagnosed Incident Cases of VTE, Men and Women, All Ages, N, Select Years, 2016-2026 27
Table 5: 7MM, One- and 10-Year Recurrent VTE Cases, Men and Women, All Ages, N, 2016 30
Table 6: Number of VTE Cases With Cancer Comorbidity, Men and Women, All Ages, N, 2016 and 2026 30
Table 7: 7MM, Number of VTE Attacks, Men and Women, All Ages, N, Select Years, 2016-2026 31
Table 8: 7MM, Number of Hospital Discharges Meeting Criteria for Medically Ill; Those at risk for VTE, Men and Women, Ages ?40 Years, N, 2016 32
Table 9: 7MM, Number of Primary Total Knee Replacements and Revisions, Men and Women, Ages ?15 Years, N, Select Years, 2016-2026 33
Table 10: 7MM, Number of Hip Replacements, Men and Women, Ages ?15 Years, N, Select Years, 2016-2026 34

1.2 List of Figures
Figure 1: 7MM, Diagnosed Incident Cases of VTE, Men and Women, All Ages, 2016 and 2026 5
Figure 2: 7MM, Number of VTE Attacks, Men and Women, All Ages, 2016 and 2026 5
Figure 3: 7MM, Age-Standardized Diagnosed Incidence of PE, All Ages, Cases per 100,000 Population, 2016 10
Figure 4: 7MM, Age-Standardized Diagnosed Incidence of DVT, All Ages, Cases per 100,000, 2016 11
Figure 5: 7MM, Sources Used to Forecast Diagnosed Incident Cases of PE and DVT, 2016 12
Figure 6: 7MM, Sources Used to Forecast the Number of Hospital Discharges that Meet the Criteria for Medically Ill. 2016 12
Figure 7: 7MM, Sources Used to Forecast Primary Total Knee Replacements and Hip Replacements. 2016 13
Figure 8: 7MM, Age-Specific Diagnosed Incident Cases of VTE, Men and Women, N 28
Figure 9: 7MM, Sex-Specific Diagnosed Incident Cases of VTE, All Ages, N, 2016 29
Filed in: Pharmaceutical
Publisher : GlobalData